Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.5.4 to the Record History and removed Revision: v3.5.3, signaling an updated version entry in the study's history.
    Difference
    0.0%
    Check dated 2026-05-15T05:19:29.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new study record revision, v3.5.3, was added to the history, and the previous revision v3.5.2 was removed from the current version list.
    Difference
    0.0%
    Check dated 2026-04-30T19:01:04.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added as the latest version, replacing v3.5.0 in the history.
    Difference
    0.0%
    Check dated 2026-04-16T11:57:16.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the Record History page and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T21:23:46.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:52:44.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T06:21:23.000Z thumbnail image

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.